NCT02206230View on ClinicalTrials.gov

Trial of Hypofractionated Radiation Therapy for Glioblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

September 25, 2014

Primary Completion Date

February 14, 2023

Study Completion Date

February 14, 2023

Conditions
Glioblastoma
Interventions
RADIATION

Hypofractionated radiation therapy

RADIATION

Standard radiation therapy

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT02206230 - Trial of Hypofractionated Radiation Therapy for Glioblastoma | Biotech Hunter | Biotech Hunter